3F-PCP

3-Fluoro-PCP (other names: 3F-PCP, 3-Fl-PCP, 3′-F-PCP, 3-fluoro Phencyclidine, Piperidine) is a designer substance of the arylcyclohexylamine family, which has a dissociative effect.

History
3F-PCP is known as a designer drug and was first discovered in the EU in 2020.

3F-PCP (Fluorocyclidine)

Chemistry
3-Fluoro-PCP is a fluorinated homologue of PCP.

Pharmacolgy
3F-PCP is relatively new and little studied, there are few data on its pharmacological and toxicological properties.
3-Fluoro-PCP is an NMDA receptor antagonist, as well as a dopamine reuptake inhibitor. 3F-PCP (Fluorocyclidine)

Effects
This drug may produce both an arousal-stimulant and a sedative state, depending on the dosage. In high doses, it may cause dissociative effects.

Legal status
Canada Schedule I,
Germany NpSG, Industrial and scientific use only,
United Kingdom Class B,
Banned in Hungary.
In some countries where PCP analogs are controlled by law, it may not be legal.
Technical Information:

Product Name: 3F-PCP
Other Name(s):  3-Fluoro-PCP , 3-Fl-PCP, 3′-F-PCP, Piperidine, 3-fluoro Phencyclidine
IUPAC Name: 1-[1-(3-fluorophenyl)cyclohexyl]piperidine
CAS: 89156-99-0
Molar Mass: 261.38 g/mol
Molecular Formula: C17H24FN
InChi Code: InChI=1S/C17H24FN/c18-16-9-7-8-15(14-16)17(10-3-1-4-11-17)19-12-5-2-6-13-19/h7-9,14H,1-6,10-13H2
InChIKey: PFPLGKFWWBXTNP-UHFFFAOYSA-N
Canonical SMILES: C1CCC(CC1)(C2=CC(=CC=C2)F)N3CCCCC3
Formulation: A crystalline solid